Category: Tinnitus Therapy

Neuromod Publishes Clinical Trial for Lenire Device

An international team, including a University of Minnesota professor, has published a second large clinical trial for a novel neuromodulation device, Lenire, that could reduce symptoms for millions worldwide with tinnitus, commonly described as “ringing in the ears.”  Researchers published the results of the Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2 (TENT-A2) clinical trial in “Nature – Scientific Reports.” An article detailing the research appears on the University of Minnesota website.

Read More

Usability of Bimodal Neuromodulation to Treat Tinnitus

It is reported that 10-15% of the global adult population suffers from tinnitus 1-4, the chronic phantom auditory percept that has been attributed to abnormal firing patterns in the brain.4 According to the American Tinnitus Association (ATA), 45 million Americans reported experiencing tinnitus in the US Centers for Disease Control (CDC) National Health and Nutritional Examination Survey.

Read More

Neuromod Launches Ótologie Tinnitus Telehealth Service

Medical device company, Neuromod Devices Ltd, announced that it has launched Ótologie, a “specialist telehealth service for tinnitus.” This new service will provide tinnitus patients, throughout the United Kingdom and Europe, with a private care option to avoid waiting lists and give them immediate access to treatment from its telehealth service.

Read More

Coping with Tinnitus

While there is no cure for tinnitus, numerous treatment options continue to emerge, including tinnitus management programs administered by hearing care professionals, hearing aids including those with tinnitus remediation features, sound therapy systems, and tinnitus coaching apps.

Read More
Loading